Copy Link Print Information

Ribociclib succinate

(Synonyms: LEE011 succinate)
84 Cited Publications
Customer Review

Based on 84 publication(s) in Google Scholar

RRibociclib (LEE011) succinate is an ATP-competitive and orally active CDK4/6 inhibitor that crosses the blood-brain barrier with IC50 values of 10 nM and 39 nM, respectively, and is over 1,000-fold less potent against the cyclin B/CDK1 complex.

For research use only. We do not sell to patients.

  • Purity: 99.93%
  • CAS No.: 1374639-75-4
  • Formula: C27H36N8O5
  • Molecular Weight:552.63
  • Storage:

    4°C, sealed storage, away from moisture

    * In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture)

  • Ribociclib succinate Chemical Structure
    Ribociclib succinate Chemical Structure
  • Experimental Validation Results for Ribociclib succinate
  • Experimental Validation Results for Ribociclib succinate
  • Experimental Validation Results for Ribociclib succinate
  • Experimental Validation Results for Ribociclib succinate
  • Experimental Validation Results for Ribociclib succinate
  • Experimental Validation Results for Ribociclib succinate
  • Experimental Validation Results for Ribociclib succinate
CAS No.: 1374639-75-4
Size
Price
Stock
Quantity
Amount: USD 0.00
Please select quantity
or
or

* Please select Quantity before adding items.

To place orders, for customer services and technical support, please contact: MedChemExpress USA

Tel: 609-228-6898 E-mail: [email protected] [email protected]

Data Download
Other Forms of Ribociclib succinate:

To place orders, for customer services and technical support, please contact:

609-228-6898
[email protected] [email protected]
Find Your Local Distributor Your local distributor: Hycultec GmbHHycultec
  • Biological Activity
  • Chemical Information
  • Solvent & Solubility
  • Protocol
  • Purity & Documentation
  • References
  • Help & FAQs
You May Still Need
Top Publications Citing

Use of MCE Products

Publications Citing Use of MedChemExpress (MCE) Ribociclib succinate

More
Customer Validation & Images
In Vivo Efficacy StudyCell Proliferation/Viability AssayWB
  • In Vivo Efficacy Study
  • Cell Proliferation/Viability Assay
  • WB
  • WB
  • WB
  • WB
  • WB

All CDK Isoforms

More
Keywords
MOQ
Minimum order quantity
100 mg

Get Quote In-stock

Other size
Get Quote
Please select quantity
Amount: USD 0.00
Sign in to MedChemExpress Sign In
Register
Sign in to MedChemExpress
Register New Account

At least 6 characters

Personalize your experience, you are currently not signed in. For a better experience, please create an online profile, you can:

Obtain points redemption prizes
Check out faster
Add multiple shipping locations
View orders
Assay Types
  • Ribociclib succinate Chemical Structure
    Ribociclib succinate Chemical Structure
    1/16
  • 1/16

    Ribociclib succinate purchased from MedChemExpress. Usage Cited in: Nat Commun. 2021 Sep 10;12(1):5386. [Abstract]

    Customer Validation
     D4476 (150  mg/kg; i.g.; daily). Combination of D4476 with Ribociclib (100  mg/kg; i.g.; daily) retards MDA-MB-231 tumor growth in vivo.

  • 1/16

    Ribociclib succinate purchased from MedChemExpress. Usage Cited in: Nat Commun. 2021 Aug 25;12(1):5112. [Abstract]

    Customer Validation
     MPF-R and TPF-R cells were treated with different concentrations of the CDK4/6 inhibitor (CDK4/6i) Palbociclib (HY-A0065), Ribociclib (HY-15777C) or Abemaciclib (HY-16297A) for 6 days. Cell growth was measured by crystal violet colorimetric assay. Growth relative to vehicle (%) is plotted against log drug concentration.

  • 1/16

    Ribociclib succinate purchased from MedChemExpress. Usage Cited in: Eur J Cancer. 2018 Oct:102:10-22. [Abstract]

    Customer Validation
     Head-to-head comparison of the effect of PD 0332991 and Ribociclib on DNA damage response (DDR) signalling in liver cancer cells.

  • 1/16

    Ribociclib succinate purchased from MedChemExpress. Usage Cited in: Mol Oncol. 2017 Aug;11(8):1035-1049. [Abstract]

    Customer Validation
     Effects of CDK4/6 inhibitors on AMPK phosphorylation and apoptosis-related signals. After 24 h of drug treatment, the cells are subjected to western blot analysis. AMPK phosphorylation level is quantified by the ratio of band intensities of phospho-AMPKα vs. AMPKα.

  • 1/16

    Ribociclib succinate purchased from MedChemExpress. Usage Cited in: Mol Oncol. 2017 Aug;11(8):1035-1049. [Abstract]

    Customer Validation
     Ribociclib induces cell death in Hep3B cells. Cells are exposed to Ribociclib at 25 μM for 72 h.

  • 1/16

    Ribociclib succinate purchased from MedChemExpress. Usage Cited in: Clin Cancer Res. 2015 Nov 1;21(21):4947-59. [Abstract]

    Customer Validation
     Retinoblastoma (RB) phosphorylation and FOXM1, another CDK4 target, are reduced in cells treated with LEE011.

  • 1/16

    Ribociclib succinate purchased from MedChemExpress. Usage Cited in: Clin Cancer Res. 2015 Nov 1;21(21):4947-59. [Abstract]

    Customer Validation
     Retinoblastoma (RB) phosphorylation and FOXM1, another CDK4 target, are reduced in cells treated with LEE011.

  • Ribociclib succinate